Clinical Trials Logo
  1. Home
  2. Human Papillomavirus Vaccines
  3. NCT06345885

Immunogenicity and Safety of One Dose of HPV Vaccine

Human Papillomavirus Vaccines Clinical Trial

Official title:
Immunogenicity and Safety of One Dose of Cecolin and One Dose of Gardasil

Clinical Trial Summary

This study will assess the immunogenicity and safety of one dose of Cecolin and one dose of Gardasil

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT06345885
Study type Interventional
Source Xiamen Innovax Biotech Co., Ltd
Contact
Status Completed
Phase Phase 4
Start date February 23, 2023
Completion date January 17, 2024
View Details
See also
  Status Clinical Trial Phase
Completed NCT03431246 - Immunogenicity of One Dose of Gardasil and One Dose of Gardasil-9 Phase 3
Active, not recruiting NCT04587167 - HPV Vaccine Communication ECHO for Primary Care Clinics N/A
Completed NCT04180462 - Increasing Optimal Use of HPV Vaccination in Primary Care N/A
Recruiting NCT05932563 - Study on the Epidemiological Characteristics of Female HPV Vaccination in China
Not yet recruiting NCT06002282 - HPV Vaccine Confident Families N/A
Terminated NCT02535845 - Developing a Self-persuasion Intervention Promoting Adolescent HPV Vaccination: Feasibility Trial N/A
Recruiting NCT05932576 - A Multicenter Cohort Study Assessing the Efficacy and Adverse Effects of HPV Vaccination in Chinese Women
Completed NCT02358083 - Attitudes Toward Human Papillomavirus and Influenza Vaccination Among Mothers of Early Adolescents N/A
Completed NCT02537756 - Developing a Self-persuasion Intervention Promoting Adolescent HPV Vaccination N/A
Completed NCT04072159 - Community Pharmacists Vaccinate Against Cancer N/A